相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial
David M Gershenson et al.
LANCET (2022)
Distribution and Effects of Estrogen Receptors in Prostate Cancer: Associated Molecular Mechanisms
Adrian Ramirez-de-Arellano et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Immune regulation in polycystic ovary syndrome
Ying-yi Luan et al.
CLINICA CHIMICA ACTA (2022)
Overexpression of Human Estrogen Biosynthetic Enzyme Hydroxysteroid (17beta) Dehydrogenase Type 1 Induces Adenomyosis-like Phenotype in Transgenic Mice
Taija Heinosalo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Site-Specific Regulation of Sulfatase and Aromatase Pathways for Estrogen Production in Endometriosis
Katiane de Almeida Da Costa et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Endocrine Therapy-Based Strategies for Metastatic Breast Cancer with Different Endocrine Sensitivity Statuses: A Systematic Review and Network Meta-Analysis
Jiani Wang et al.
CANCERS (2022)
An irreversible inhibitor of 17?-hydroxysteroid dehydrogenase type 1 inhibits estradiol synthesis in human endometriosis lesions and induces regression of the non-human primate endometriosis
Donald Poirier et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2022)
Investigation of biomarkers in Endometriosisassociated infertility: Systematic Review
Erika M. Egashira et al.
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2022)
Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis
Abdelrahman Mohamed et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosis
Sarah Boddy et al.
BRAIN COMMUNICATIONS (2022)
ESHRE guideline: endometriosis
Christian M. Becker et al.
HUMAN REPRODUCTION OPEN (2022)
N-Phenyl-1,2,3,4-tetrahydroisoquinoline: An Alternative Scaffold for the Design of 17β-Hydroxysteroid Dehydrogenase 1 Inhibitors
Marco Mottinelli et al.
CHEMMEDCHEM (2021)
Heterocyclic androstane and estrane D-ring modified steroids: Microwave-assisted synthesis, steroid-converting enzyme inhibition, apoptosis induction, and effects on genes encoding estrogen inactivating enzymes
Agnes Erika Kulmany et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer
Willem Jan van Weelden et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)
Steroid sulfatase inhibitors: the current landscape
Hanan S. Anbar et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2021)
Steroid Sulfation in Adrenal Tumors
Jonathan Wolf Mueller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Steroid Sulphatase and Its Inhibitors: Past, Present, and Future
Paul A. Foster
MOLECULES (2021)
Correlation between steroid levels in follicular fluid and hormone synthesis related substances in its exosomes and embryo quality in patients with polycystic ovary syndrome
Li Yu et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2021)
A Targeted-Covalent Inhibitor of 17β-HSD1 Blocks Two Estrogen-Biosynthesis Pathways: In Vitro (Metabolism) and In Vivo (Xenograft) Studies in T-47D Breast Cancer Models
Donald Poirier et al.
CANCERS (2021)
Estimated Projection of US Cancer Incidence and Death to 2040
Lola Rahib et al.
JAMA NETWORK OPEN (2021)
Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team
V. Craig Jordan
BREAST CANCER RESEARCH AND TREATMENT (2021)
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer
Filipa Lynce et al.
CANCER (2021)
Pharmacological inhibition of 17β-hydroxysteroid dehydrogenase impairs human endometrial cancer growth in an orthotopic xenograft mouse model
Sofia Xanthoulea et al.
CANCER LETTERS (2021)
Extended Aromatase Inhibitors in Hormone-Receptor-Positive Breast Cancer
Pamela J. Goodwin
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Synthesis of 16β-derivatives of 3-(2-bromoethyl)-estra-1,3,5 (10)-trien-17β-ol as inhibitors of 17β-HSD1 and/or steroid sulfatase for the treatment of estrogen-dependent diseases
Maxime Lesperance et al.
STEROIDS (2021)
Simultaneous expression of steroid sulfatase and androgen receptor reduced overall survival of patients with epithelial ovarian tumors
Argelia Calvillo-Robledo et al.
JOURNAL OF OVARIAN RESEARCH (2021)
Influence of CYP19A1 gene expression levels in women with breast cancer: a systematic review of the literature
Maria da Conceicao Barros-Oliveira et al.
CLINICS (2021)
Estrogen Receptor Pathway Activity Score to Predict Clinical Response or Resistance to Neoadjuvant Endocrine Therapy in Primary Breast Cancer
Marcia A. Inda et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Aromatase inhibitors: Role in postmenopausal breast cancer
Rajeev Kharb et al.
ARCHIV DER PHARMAZIE (2020)
Endometriosis
Krina T. Zondervan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate Cancer
Cameron M. Armstrong et al.
CLINICAL CANCER RESEARCH (2020)
Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers
Gerardo Colon-Otero et al.
ESMO OPEN (2020)
Role of hydroxysteroid (17beta) dehydrogenase type 1 in reproductive tissues and hormone-dependent diseases
Taija Heinosalo et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Polyphenolic natural products and natural product-inspired steroidal mimics as aromatase inhibitors
Alexander J. Nielsen et al.
MEDICINAL RESEARCH REVIEWS (2019)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type I in an optimized xenograft cell and molecular biology model in vivo
Fang Li et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Estrogen Receptor Covalent Antagonists: The Best Is Yet to Come
Craig Furman et al.
CANCER RESEARCH (2019)
Anti-estrogen Treatment in Endometrial Cancer: A Systematic Review
Willem Jan van Weelden et al.
FRONTIERS IN ONCOLOGY (2019)
Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials
M. Martin et al.
EUROPEAN JOURNAL OF CANCER (2019)
Development of potential preclinical candidates with promising in vitro ADME profile for the inhibition of type 1 and type 2 17β-Hydroxysteroid dehydrogenases: Design, synthesis, and biological evaluation
Ahmed S. Abdelsamie et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Rethinking mechanisms, diagnosis and management of endometriosis
Charles Chapron et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
The Multiple Biological Targets of Hops and Bioactive Compounds
Judy L. Bolton et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2019)
Inhibitors of 17β-hydroxysteroid dehydrogenase type 1, 2 and 14: Structures, biological activities and future challenges
Mohamed Salah et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Local estrogen metabolism (intracrinology) in endometrial cancer: A systematic review
K. M. C. Cornel et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Design, synthesis, and biological evaluation of novel androst-17β-amide structurally related compounds as dual 5α-reductase inhibitors and androgen receptor antagonists
Kejing Lao et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Synthesis of substituted 15β-alkoxy estrone derivatives and their cofactor-dependent inhibitory effect on 17β-HSD1
Bianka Edina Herman et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls
Selma Feldman Witchel et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2019)
In breast cancer subtypes steroid sulfatase (STS) is associated with less aggressive tumour characteristics
Keely M. McNamara et al.
BRITISH JOURNAL OF CANCER (2018)
HSD17B1 expression induces inflammation-aided rupture of mammary gland myoepithelium
Paivi Jarvensivu et al.
ENDOCRINE-RELATED CANCER (2018)
被撤回的出版物: Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: ALTERNATIVE (Retracted article. See vol. 39, pg. 95, 2021)
Stephen R. D. Johnston et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Blocking oestradiol synthesis pathways with potent and selective coumarin derivatives
Sanna Niinivehmas et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
Contribution of intracrine oestrogens to the aetiology of endometriosis
Carla A. Piccinato et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
Blocking 17β-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach
Gonda F. J. Konings et al.
JOURNAL OF PATHOLOGY (2018)
Obesity and breast cancer - Role of estrogens and the molecular underpinnings of aromatase regulation in breast adipose tissue
Celine Gerard et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Polycystic Ovary Syndrome
Ricardo Azziz
OBSTETRICS AND GYNECOLOGY (2018)
Estrogen-related receptor γ regulates expression of 17β-hydroxysteroid dehydrogenase type 1 in fetal growth restriction
Hui Zhu et al.
PLACENTA (2018)
Elevated Aromatase (CYP19A1) Expression Is Associated with a Poor Survival of Patients with Estrogen Receptor Positive Breast Cancer
Andrea Friesenhengst et al.
HORMONES & CANCER (2018)
Estrogens and Their Receptors in Prostate Cancer: Therapeutic Implications
Erika Di Zazzo et al.
FRONTIERS IN ONCOLOGY (2018)
Development of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure
Gonda F. J. Konings et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The sulfatase pathway as estrogen supply in endometrial cancer
K. M. C. Cornel et al.
STEROIDS (2018)
Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery
Gonda Konings et al.
FRONTIERS IN PHARMACOLOGY (2018)
A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer
Patricia Pautier et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial
Ian E. Krop et al.
LANCET ONCOLOGY (2017)
Increased levels of enzymes involved in local estradiol synthesis in chronic obstructive pulmonary disease
G. F. J. Konings et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Polycystic Ovarian Syndrome: Long-Term Health Consequences
Temeka Zore et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2017)
Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer
Felicitas Mungenast et al.
ONCOLOGY LETTERS (2017)
The Significance of the Sulfatase Pathway for Local Estrogen Formation in Endometrial Cancer
Masa Sinreih et al.
FRONTIERS IN PHARMACOLOGY (2017)
The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers
Tea Lanisnik Rizner et al.
FRONTIERS IN PHARMACOLOGY (2017)
Epidemiology of uterine fibroids: a systematic review
E. A. Stewart et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2017)
IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients
Carlo Palmieri et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
A Review of Fulvestrant in Breast Cancer
Mark R. Nathan et al.
ONCOLOGY AND THERAPY (2017)
Dyspareunia and depressive symptoms are associated with impaired sexual functioning in women with endometriosis, whereas sexual functioning in their male partners is not affected
A. A. De Graaff et al.
HUMAN REPRODUCTION (2016)
Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T-DM1) vs. treatment of physician's choice in previously treated HER2-positive advanced breast cancer
Sung-Bae Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Effects of steroid hormone on estrogen sulfotransferase and on steroid sulfatase expression in endometriosis tissue and stromal cells
Carla A. Piccinato et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
Expanding the view of breast cancer metabolism: Promising molecular targets and therapeutic opportunities
John P. Harrelson et al.
PHARMACOLOGY & THERAPEUTICS (2016)
The Role of Steroid Sulfatase as a Prognostic Factor in Patients with Endometrial Cancer
Won Moo Lee et al.
YONSEI MEDICAL JOURNAL (2016)
Projections of cancer incidence and cancer-related deaths inGermany by 2020 and 2030
Anne S. Quante et al.
CANCER MEDICINE (2016)
The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases
Tea Lanisnik Rizner
FRONTIERS IN PHARMACOLOGY (2016)
Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcome
Thea Grindstad et al.
SCIENTIFIC REPORTS (2016)
Depurinating estrogen-DNA adducts, generators of cancer initiation: their minimization leads to cancer prevention
Ercole L. Cavalieri et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2016)
The Regulation of Steroid Action by Sulfation and Desulfation
Jonathan W. Mueller et al.
ENDOCRINE REVIEWS (2015)
Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer
Irshad Ahmad et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma
Brian M. Slomovitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy
Xia Ren et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential
Mark P. Thomas et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Recent Patents on New Steroid Agents Targeting the Steroidogenesis for Endocrine Cancer Treatments
Donald Poirier
RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY (2015)
Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerations
Marcello Maugeri-Sacca et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Selection of Personalized Patient Therapy through the Use of Knowledge-Based Computational Models That Identify Tumor-Driving Signal Transduction Pathways
Wim Verhaegh et al.
CANCER RESEARCH (2014)
The Increase in Thyroid Cancer Incidence During the Last Four Decades Is Accompanied by a High Frequency of BRAF Mutations and a Sharp Increase in RAS Mutations
Chan Kwon Jung et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial
Ian E. Krop et al.
LANCET ONCOLOGY (2014)
Synergistic Effects of E2MATE and Norethindrone Acetate on Steroid Sulfatase Inhibition: A Randomized Phase I Proof-of-Principle Clinical Study in Women of Reproductive Age
Oliver Pohl et al.
REPRODUCTIVE SCIENCES (2014)
Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2
Shinzaburo Noguchi et al.
BREAST CANCER (2014)
A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer
R. Charles Coombes et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey
A. A. De Graaff et al.
HUMAN REPRODUCTION (2013)
Medical treatment improves social behavior in a primate endometriosis model (Callithrix jacchus)
C. Arnold et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2013)
Estrogen biosynthesis, phase I and phase II metabolism, and action in endometrial cancer
Tea Lanišnik Rižner
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres
Steven Simoens et al.
HUMAN REPRODUCTION (2012)
Overexpression of 17β-Hydroxysteroid Dehydrogenase Type 1 Increases the Exposure of Endometrial Cancer to 17β-Estradiol
Karlijn M. C. Cornel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Estrogen biosynthesis and signaling in endometriosis
Kaisa Huhtinen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Serum sex steroids measured in middle-aged European and African-Caribbean men by gas chromatography-mass spectrometry
Frank Giton et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Profiling of Endogenous Estrogens, Their Precursors, and Metabolites in Endometrial Cancer Patients: Association with Risk and Relationship to Clinical Characteristics
Etienne Audet-Walsh et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Aromatase, aromatase inhibitors, and breast cancer
Saranya Chumsri et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Steroid sulfatase inhibitors: A review covering the promising 2000-2010 decade
Rene Maltais et al.
STEROIDS (2011)
Hybrid Dual Aromatase-Steroid Sulfatase Inhibitors with Exquisite Picomolar Inhibitory Activity
L. W. Lawrence Woo et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Extending aromatase inhibitor sensitivity in hormone resistant breast cancer
Angela M. H. Brodie et al.
HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION (2011)
Novel Hydroxysteroid (17β) Dehydrogenase 1 Inhibitors Reverse Estrogen-Induced Endometrial Hyperplasia in Transgenic Mice
Taija Saloniemi et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer
Rob Riemsma et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
17 beta-Hydroxysteroid dehydrogenase inhibitors: a patent review
Donald Poirier
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Endometrial cancer incidence trends in Norway during 1953-2007 and predictions for 2008-2027
Kristina Lindemann et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Circulating Estrogens in Endometrial Cancer Cases and Their Relationship with Tissular Expression of Key Estrogen Biosynthesis and Metabolic Pathways
Johanie Lepine et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Highly Potent First Examples of Dual Aromatase-Steroid Sulfatase Inhibitors based on a Biphenyl Template
L. W. Lawrence Woo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Species Used for Drug Testing Reveal Different Inhibition Susceptibility for 17beta-Hydroxysteroid Dehydrogenase Type 1
Gabriele Moeller et al.
PLOS ONE (2010)
Estrone sulfatase activity in patients with advanced ovarian cancer
Justin C. Chura et al.
GYNECOLOGIC ONCOLOGY (2009)
The Expanding Use of Third-Generation Aromatase Inhibitors: What the General Internist Needs to Know
Susan Hong et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2009)
Estrogen metabolism and action in endometriosis
Tea Lanisnik Rizner
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Estrone C15 derivatives-A new class of 17β-hydroxysteroid dehydrogenase type 1 inhibitors
Josef Messinger et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer
Tina Smuc et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women
Lorna Gibson et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)
A New Therapeutic Strategy against Hormone-Dependent Breast Cancer: The Preclinical Development of a Dual Aromatase and Sulfatase Inhibitor
Paul A. Foster et al.
CLINICAL CANCER RESEARCH (2008)
Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1
S. Gobec et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: Intention-to-treat analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 trial
Eleftherios P. Mamounas et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer:: Update of study BIG 1-98
Alan S. Coates et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
FRA1E common fragile site breaks map within a 370 kilobase pair region and disrupt the dihydropyrimidine dehydrogenase gene (DPYD)
Fabiola Hormozian et al.
CANCER LETTERS (2007)
Letrozole in the extended adjuvant setting: MA.17
Paul E. Goss
BREAST CANCER RESEARCH AND TREATMENT (2007)
Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormonesensitive early-stage breast cancer: a meta-analysis
Walter Jonat et al.
LANCET ONCOLOGY (2006)
Human hydroxysteroid (17-β) dehydrogenase 1 expression enhances estrogen sensitivity of MCF-7 breast cancer cell xenografts
Bettina Husen et al.
ENDOCRINOLOGY (2006)
Steroid sulfatase and estrogen sulfotransferase in human prostate cancer
Yasuhiro Nakamura et al.
PROSTATE (2006)
Induction of endometriosis in the marmoset monkey (Callithrix jacchus)
A. Einspanier et al.
MOLECULAR HUMAN REPRODUCTION (2006)
Evaluation of inhibitors for 17β-hydroxysteroid dehydrogenase type 1 in vivo in immunodeficient mice inoculated with MCF-7 cells stably expressing the recombinant human enzyme
B Husen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
Phase I study of STX 64 (667 Coumate) in breast cancer patients: The first study of a steroid sulfatase inhibitor
SJ Stanway et al.
CLINICAL CANCER RESEARCH (2006)
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCICCTG MA.17
PE Goss et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
RC Coombes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer - Results of the ATAC (arimidex, tamoxifen alone or in comhination) trial efficacy and safety update analyses
CANCER (2003)
Breast cancer prevention - clinical trials strategies involving aromatase inhibitors
PE Goss
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Drug therapy: Aromatase inhibitors in breast cancer
IE Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Aromatase inhibitors in breast cancer
A Brodie
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2002)
Steroid sulfatase expression in ovarian clear cell adenocarcinoma: Immunohistochemical study
T Okuda et al.
GYNECOLOGIC ONCOLOGY (2001)
分享论文
